The US Food and Drug administration (FDA) has granted an Emergency Use Authorization (EUA) for the bamlanivimab-etesevimab antibody cocktail made by Eli Lilly for...
Eli Lilly is to buy Prevail Therapeutics, a US biotech focused on developing adeno-associated viral vector 9 (AAV9) gene therapies to treat neurodegenerative diseases, in...
Eli Lilly is wading into gene therapy, inking a deal with Precision BioSciences to develop in vivo gene therapies for three gene targets. The first target will be...
US medical research agency the National Institutes of Health (NIH) has paused a Phase 3 study on Eli Lilly’s Covid-19 antibody treatment on a potential safety concern.
15.04.2020
- The pharmaceutical industry has been slowly, but surely, embracing continuous manufacturing (CM) over the past decade. In fact, most large pharma companies have invested in...
14.04.2020
- Established in 2004 by the International Society for Pharmaceutical Engineering (ISPE), the Facility of the Year Awards (FOYA) recognize innovation and creativity in manufacturing...
09.04.2020
- Eli Lilly has formed an exclusive global licensing and research partnership in immunology with UK biopharma Sitryx. The collaboration is focused on regulating cell metabolism to...
24.01.2020
- US drugmaker Eli Lilly is planning to invest $474 million in a new plant in North Carolina’s Research Triangle Park (RTP) that will produce injectable medicines such as insulin, as...
